Given the importance of STING activation in the efficacy of anti-PD-1/PD-L1 therapies (4), we next determined the effect of SIX4 expression on the efficiency of an anti-PD-1 antibody-mediated inhibition of tumor growth in immune competent mice. The gene discussed is STING1; the disease is neoplasm.